Calcitriol 1μg

Calcitriol 1μg
Product Description

1. Efficacy & Effectiveness

1) Treatment for hypocalcemia in chronic kidney dialysis patients.

2) Improvement of skeletal dysplasia by remarkable reducing elevated parathyroid hormone levels.

2. Administration & Dosage

The initial recommended dose of the drug, as calcitriol, is administered three times a week with 0.5 µg (about 0.01 µg per kg body weight) every other day. the drug, an IV bolus, can be administered through a catheter at the end of hemodialysis. If a satisfactory response does not appear on the biochemical reference ​​and clinical observation, the amount is increased from 0.25 to 0.50 ㎍ every 2 to 4 weeks. Most patients on hemodialysis show an effect at a dose of 0.5 to 3.0 µg (0.05 to 0.05 µg per kg body weight) three times a week. ○ Cautions for use 1) Serum calcium and phosphorus levels should be measured at least twice a week during the appropriate period...

YUYU PHARMA

  • KR
  • 2023
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Distributor/Import Export
Generics/Biosimilars Manufacturer
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Finished Formulation products Distributor/Buyer
OTC
Pharmaceutical Company (generic finished products)
Specifications

YUYU PHARMA

  • KR
  • 2023
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Distributor/Import Export
Generics/Biosimilars Manufacturer
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Finished Formulation products Distributor/Buyer
OTC
Pharmaceutical Company (generic finished products)

More Products from YUYU PHARMA (3)

  • Dutasteride and Tadalafil Tablet 0.5/5 mg

    Product Dutasteride and Tadalafil Tablet 0.5/5 mg

    We have developed novel combination of marketed individual Dutasteride and Tadalafil (Avodart + Cialis) for BPH indication. The combination of tadalafil with dutasteride provide better therapeutic effect in improvement of BPH and LUTs symptoms while reduce adverse effect profile particularly Erectile d...
  • Dutasteride and Tamsulosin HCl Capsules 0.5/0.4 mg

    Product Dutasteride and Tamsulosin HCl Capsules 0.5/0.4 mg

    We have developed novel small capsules of marketed Dutasteride and Tamsulosin HCl Capsules (Jalyn/Duodart/Combodart)) for BPH indication. The marketed product is a big pill, 23mm in length above FDA’s recommendation (22mm). Large pill size of marketed product considered burdensome for patients; potenti...
  • Dutasteride Tablet 0.5 mg

    Product Dutasteride Tablet 0.5 mg

    We have developed novel small tablet of marketed Dutasteride Softgel (Avodart) for BPH and acute urinary retention indication. This small pill will help to resolve swallowing difficulties in elder population where BPH in more prevalent (80% Male at 80 Yr old).

    The product development...